Lynch Syndrome
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Increasing recognition of the statistical burden posed by HNPCC (5 to 6 percent of all colorectal cancer) mandates that physicians have a better understanding of the genetics, natural history, and distinction between the hereditary site-specific variant (Lynch syndrome I) and the Cancer Family Syndrome (Lynch syndrome II).
|
3366037 |
1988 |
Lynch Syndrome
|
0.700 |
Biomarker
|
disease |
CLINGEN |
Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells.
|
7604264 |
1995 |
Lynch Syndrome
|
0.700 |
Biomarker
|
disease |
CLINGEN |
GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells.
|
7604265 |
1995 |
Lynch Syndrome
|
0.700 |
Biomarker
|
disease |
CTD_human |
Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer.
|
9354786 |
1997 |
Lynch Syndrome
|
0.700 |
Biomarker
|
disease |
CLINGEN |
Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer.
|
9354786 |
1997 |
Lynch Syndrome
|
0.700 |
Biomarker
|
disease |
CLINGEN |
Mutation in the mismatch repair gene Msh6 causes cancer susceptibility.
|
9390556 |
1997 |
Lynch Syndrome
|
0.700 |
Biomarker
|
disease |
CLINGEN |
Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations.
|
10521294 |
1999 |
Lynch Syndrome
|
0.700 |
Biomarker
|
disease |
CLINGEN |
HNPCC-like cancer predisposition in mice through simultaneous loss of Msh3 and Msh6 mismatch-repair protein functions.
|
10545954 |
1999 |
Lynch Syndrome
|
0.700 |
Biomarker
|
disease |
CLINGEN |
MSH6 and MSH3 are rarely involved in genetic predisposition to nonpolypotic colon cancer.
|
11245474 |
2001 |
Lynch Syndrome
|
0.700 |
Biomarker
|
disease |
CTD_human |
A role for MLH3 in hereditary nonpolyposis colorectal cancer.
|
11586295 |
2001 |
Lynch Syndrome
|
0.700 |
Biomarker
|
disease |
CLINGEN |
Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant.
|
11709755 |
2002 |
Lynch Syndrome
|
0.700 |
Biomarker
|
disease |
BEFREE |
Germ-line mutations in the mismatch-repair genes MLH1, MSH2, MSH6, and PMS2 lead to the development of the Lynch syndrome (hereditary nonpolyposis colorectal cancer), conferring a strong susceptibility to cancer.
|
15872200 |
2005 |
Lynch Syndrome
|
0.700 |
Biomarker
|
disease |
BEFREE |
These MSH6 families, despite their late age of onset, have a high lifetime risk of all Lynch syndrome-related cancers, significantly higher in women (89% by age 80) than in men (69%).
|
16283884 |
2005 |
Lynch Syndrome
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Families suspected of Lynch syndrome (n = 614) were analysed for microsatellite instability, MLH1 promoter methylation and/or germline mutations in MLH1, MSH2, MSH6, and PMS2.
|
17453009 |
2007 |
Lynch Syndrome
|
0.700 |
Biomarker
|
disease |
BEFREE |
Heterozygous germline mutations in mismatch repair (MMR) genes MLH1, PMS2, MSH2, and MSH6 cause Lynch syndrome.
|
17851451 |
2008 |
Lynch Syndrome
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Most recently, MYH-associated polyposis (MAP) and an "atypical Lynch syndrome" related to the presence of MSH6 mutations have been linked to an increased risk of CRC.
|
17920897 |
2007 |
Lynch Syndrome
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Lynch syndrome is primarily due to germline mutations in one of the DNA MMR genes; mainly hMLH1 or hMSH2 and less frequently hMSH6 and rarely hPMS2.
|
17942460 |
2008 |
Lynch Syndrome
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Comprehensive analysis of the mismatch repair genes associated with Lynch syndrome revealed a germline hMSH6 missense mutation 2314C>T (arg772trp) and normal sequencing for hMSH2 and hMLH1.
|
18176851 |
2008 |
Lynch Syndrome
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Lynch syndrome is the predisposition to visceral malignancies that are associated with deleterious germline mutations in DNA mismatch repair genes, including MLH1, MSH2, MSH6, and PMS2.
|
18270343 |
2008 |
Lynch Syndrome
|
0.700 |
Biomarker
|
disease |
CTD_human |
Lack of DNA mismatch repair protein MSH6 in the rat results in hereditary non-polyposis colorectal cancer-like tumorigenesis.
|
18417481 |
2008 |
Lynch Syndrome
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Major contribution from recurrent alterations and MSH6 mutations in the Danish Lynch syndrome population.
|
18566915 |
2009 |
Lynch Syndrome
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The aim of the present study was to evaluate the contribution of MSH6 gene mutations in families that were analysed for Lynch syndrome in a diagnostic setting.
|
18625694 |
2008 |
Lynch Syndrome
|
0.700 |
Biomarker
|
disease |
CLINGEN |
Hereditary cancer-associated missense mutations in hMSH6 uncouple ATP hydrolysis from DNA mismatch binding.
|
18790734 |
2008 |
Lynch Syndrome
|
0.700 |
Biomarker
|
disease |
BEFREE |
It is well-established that germline mutations in the mismatch repair genes MLH1, MSH2, and MSH6 cause Lynch syndrome.
|
19132747 |
2009 |
Lynch Syndrome
|
0.700 |
Biomarker
|
disease |
BEFREE |
Using a multimodal approach, we have identified mutations in MLH1, MSH2, and MSH6 in French Canadian families fulfilling the Amsterdam criteria for Lynch syndrome and who displayed abnormal staining for at least one of the Lynch syndrome proteins.
|
19459153 |
2009 |